Phase 1 Dose Escalation Study of STM-416p

Phase 1 Dose Escalation Study of STM-416p administered intraoperatively to patients undergoing radical prostatectomy.

A Phase 1 trial with the primary objective of assessing the safety and tolerability of an immunotherapy investigational product administered intraoperatively to participants with prostate cancer undergoing radical prostatectomy.

Research Projects

See All
CaverSTIM

World first medical device implantation to restore erectile function
ProstACT

A global study to evaluate investigational radionuclide therapy
ACT for Erectile Dysfunction

Erectile Dysfunction Adaptation of ACT for Compliance with an Erectile Rehabilitation Program
Tissue Banking

We contribute over 60% of the advanced metastatic prostate cancer samples analysed globally.
Pan Prostate Cancer Group

As part of this global group we analyse genetic data from over 1800 men with prostate cancer.
Genetic Research Program

Identifying different types of prostate cancer and enabling targeted treatment.
Ironman Study

International registry for men with advanced prostate cancer.
PRECEPT

Improving methods of diagnosis treatment for individuals with potentially lethal prostate cancer.
Survivorship Research

Identifying different types of prostate cancer and enabling targeted treatment.

Partner with us

Contact our research team at APC to find out how you can partner with us and get involved with our ground-breaking research.

Get in touch